Healthcare systems across the world are under increasing pressure. Growing patient demand, workforce shortages and limited clinical capacity continue to place urgent and primary care services under strain, prompting healthcare leaders to explore new ways of improving access while maintaining high standards of patient safety.

Artificial intelligence is emerging as one of the technologies helping to address this challenge. Rather than replacing clinicians, AI-powered clinical decision support tools are being developed to help patients access the right level of care more quickly, improve clinical workflows and make better use of valuable healthcare resources.

One company at the forefront of this field is Infermedica, a sponsor of GIANT Health 2026, whose clinically validated AI-powered Medical Guidance Platform is already supporting healthcare organisations around the world.

Improving Access Through Intelligent Clinical Triage

One of the biggest challenges facing healthcare providers is ensuring that patients are directed to the most appropriate care pathway from the moment they first seek help. Many people are unsure whether they should manage symptoms at home, book an appointment with their GP, visit an urgent treatment centre or attend A&E. At the same time, healthcare services must prioritise limited clinical resources for those who need them most.

Infermedica's Clinical AI Triage has been designed to help solve this problem. Using advanced clinical algorithms and a comprehensive medical knowledge base, the platform assesses a patient's symptoms and recommends the most appropriate next step based on their individual circumstances.

This helps patients access suitable care more quickly while supporting healthcare providers in reducing unnecessary demand and improving operational efficiency.

The platform is built on more than 160,000 hours of physician expertise and is now used by over 100 organisations in more than 30 countries, demonstrating the growing global confidence in AI-assisted patient navigation.

Importantly, Infermedica's Medical Guidance Platform is certified as a Class IIb medical device under the EU Medical Device Regulation (MDR) and is registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA), providing healthcare organisations with confidence in its clinical governance and regulatory compliance.

Clinical Expertise Driving Responsible AI

As AI becomes increasingly embedded within healthcare, clinical leadership remains essential to ensuring these technologies are safe, evidence-based and capable of delivering meaningful improvements for patients and healthcare professionals alike.

This commitment is reflected in the work of Dr. Charles Young, Chief Medical Officer at Infermedica.

An experienced clinician, healthcare researcher and medical leader, Dr. Young has spent his career working with healthcare systems across the UK and internationally. His experience spans collaboration with governments, healthcare providers, commercial organisations and not-for-profit institutions, giving him a broad perspective on the challenges facing modern health systems.

At Infermedica, he leads clinical strategy, medical governance and the ongoing validation of the company's AI-powered digital triage solutions, helping ensure that innovation remains firmly rooted in clinical evidence and patient safety.

Discussing the Future of AI Triage at GIANT Health 2026

Visitors to GIANT Health 2026 will have the opportunity to hear directly from Dr. Young during his presentation:

Health systems globally are failing. AI triage is an essential part of the solution.

Stage B, The NHS National AI Conference
Tuesday, 8 December 2026
15:15–15:25

Drawing on his extensive clinical and leadership experience, Dr. Young will explore why healthcare systems worldwide are reaching a critical point, how AI-powered triage can support more sustainable models of care, and why clinically governed artificial intelligence is becoming an increasingly important part of healthcare transformation.

The session is expected to provide valuable insights for NHS leaders, clinicians, commissioners, digital health innovators and anyone interested in the practical application of AI within modern healthcare.

Meet Infermedica at GIANT Health 2026

GIANT Health has long provided a platform for organisations developing technologies that can make a measurable difference to healthcare delivery. Infermedica's participation reflects the growing importance of clinically validated AI solutions that support both patients and healthcare professionals.

Throughout the event, attendees will have the opportunity to meet the Infermedica team, learn more about the company's Medical Guidance Platform and discuss how AI-powered clinical triage can help healthcare organisations improve patient access, optimise care pathways and build more resilient healthcare systems.

As conversations around the future of digital health continue to evolve, AI-powered clinical triage is becoming an increasingly important part of that discussion. GIANT Health 2026 provides an ideal opportunity to explore how organisations such as Infermedica are helping shape the next generation of healthcare delivery.

Join us on 7–8 December 2026 at the Business Design Centre, London, to meet Infermedica and discover the latest innovations transforming healthcare through clinically validated artificial intelligence.